SNZZF (Senzime AB) Moat Score: 3/10 (As of Jul. 05, 2026)


SNZZF Senzime AB SNZZF
71 GF Score
Price $0.48
GF Value $1.19
Valuation Possible Value Trap
! 2 Warning Signs
View Full Analysis

What is Senzime AB Moat Score?

Senzime AB SNZZF 71 Moat Score is 3 as of Jul. 05, 2026. GuruFocus rates SNZZF with a GF Score™ of 71/100 and a GF Value™ of $1.19 (Possible Value Trap). The stock has 2 warning signs investors should review. Among 845 Medical Devices & Instruments companies, Senzime AB ranks better than 75.86% on this metric.

Senzime AB has the Moat Score of 3, which implies that the company might have No Moat - Very weak/transient advantages.

Senzime AB has No Moat: Senzime AB operates in a competitive medical technology market with limited market leadership and no significant network effects or customer switching costs. The company lacks strong brand strength, durable cost advantages, or significant regulatory barriers. Its intellectual property and innovation capabilities are not sufficient to establish a sustainable competitive advantage.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Senzime AB might have No Moat - Very weak/transient advantages.

Senzime AB  (OTCPK:SNZZF) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Senzime AB Moat Score Related Terms

SNZZF vs ABT, SYK, MDT: Moat Score Comparison

For the Medical Devices subindustry, Senzime AB's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Senzime AB Moat Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Senzime AB's Moat Score distribution charts can be found below:

* The bar in red indicates where Senzime AB's Moat Score falls into.


SNZZF
71GF Score
Senzime AB SNZZF
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 3 mean?
Senzime AB (SNZZF) has a Moat Score of 3 as of Jul. 05, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Senzime AB ranks #204 out of 845 companies in the Medical Devices & Instruments industry, placing it in the top 24.1%.
Is Senzime AB's Moat Score too high?
Senzime AB's current Moat Score is 3. Based on the distribution chart, Senzime AB ranks #204 out of 845 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Senzime AB has a GF Score™ of 71/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Senzime AB's Moat Score compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Senzime AB ranks #204 out of 845 companies for Moat Score. This places Senzime AB in the top 24% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Medical Devices & Instruments company?
A good Moat Score depends on the Medical Devices & Instruments industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Senzime AB's current Moat Score is 3. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Senzime AB stock overvalued right now?
Based on GuruFocus' analysis, Senzime AB (SNZZF) is currently considered Possible Value Trap. The stock's GF Value™ is $1.19, compared to a current price of $0.48 — trading 59.8% below its estimated fair value. The current Moat Score is 3. Senzime AB's overall GF Score™ is 71/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Senzime AB (SNZZF), the current Moat Score is 3 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Senzime AB (SNZZF) Overvalued in 2026?

Based on GuruFocus' analysis, Senzime AB stock appears to be undervalued. The current stock price of $0.48 is trading 59.8% below its estimated GF Value™ of $1.19. GuruFocus considers Senzime AB to be Possible Value Trap.

Key valuation signals for SNZZF:

  • Moat Score: 3
  • GF Value™: $1.19 vs. price of $0.48 (59.8% below fair value)
  • GF Score™: 71/100 with 2 warning signs

No single metric tells the full story. See the SNZZF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Senzime AB Business Description

Other Exchanges SEZI:Sweden6YC:Germany
Address Verkstadsgatan 8, hus 1, Uppsala, SWE, 753 23
Senzime AB is a medical device company developing precision-based patient monitoring solutions for patients undergoing anesthesia. The company develops and markets precision-based monitoring systems for monitoring neuromuscular function and respiration during and after surgery, as well as for intensive care. Its product portfolio includes Next-generation TetraGraph, TetraGraph connectivity, TetraGraph for pediatric, Classic TetraGraph, and ExSpiron. The TetraGraph system is used in thousands of operating rooms internationally in university hospitals, public, private, military, and veterans hospitals. Senzime has direct sales resources in the USA and Germany and collaborates with distributors and licensees in its other main markets.
71GF Score

Get the complete analysis for SNZZF

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.48
Price
$1.19
GF Value